CytoDyn (CYDY) Treasury Shares (2011 - 2026)

CytoDyn (CYDY) posted Treasury Shares of $286.0 for Q2 2020, little changed on a QoQ basis from $286.0 in Q1 2020, and up 79.87% year-over-year from $159.0 in Q2 2019.

CytoDyn (CYDY) Treasury Shares (2011 - 2026) Analysis & Trends

CytoDyn's Treasury Shares history runs 7 years deep, the most recent figure standing at $286.0 for Q2 2020.

  • Quarterly Treasury Shares rose 79.87% year-over-year to $286.0 in Q2 2020, while the trailing twelve-month figure through May 2020 was $286.0 (up 79.87% YoY) and the FY2020 annual result came in at $286.0, up 79.87% from the prior year.
  • Treasury Shares was $286.0 for Q2 2020 at CytoDyn, roughly flat from $286.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.5 million in Q2 2025 and bottomed at $286000.0 in Q1 2025.
  • A 5-year average of $1.3 million and a median of $443000.0 in 2022 frame the typical range for Treasury Shares.
  • Annual changes were most pronounced in 2019 — Treasury Shares changed 0.0% — and 2020, when it soared 79.87%.
  • CytoDyn's Treasury Shares stood at $159.0 in 2018, then changed by 0.0% to $159.0 in 2019, then surged by 79.87% to $286.0 in 2020.
  • Business Quant data shows CYDY's Treasury Shares at $286.0 in Q2 2020, $286.0 in Q1 2020, and $159.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -21,709.08
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 265,401.92
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 19.41 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 5.14 Mn
10 CytoDyn 267.79 Mn 267.79 Mn - 3.50 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 3.50 Mn
Feb 28, 2026 3.50 Mn
Nov 30, 2025 3.50 Mn
Nov 30, 2025 3.50 Mn
Aug 31, 2025 3.50 Mn
Aug 31, 2025 3.50 Mn
May 31, 2025 3.50 Mn
May 31, 2025 3.50 Mn
Feb 28, 2025 286,000.00
Feb 28, 2025 286,000.00
Nov 30, 2024 443,000.00
Nov 30, 2024 443,000.00
Aug 31, 2024 443,000.00
Aug 31, 2024 443,000.00
May 31, 2024 443,000.00
May 31, 2024 443,000.00
Feb 29, 2024 443,000.00
Feb 29, 2024 443,000.00
Nov 30, 2023 443,000.00
Nov 30, 2023 443,000.00